Gilead Sciences Inc.
0
0
0%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 7.8B 7.1B 6.7B 7.6B
Cost of revenue 1.6B 1.5B 1.5B 1.6B
Gross profit 6.2B 5.6B 5.1B 6.0B
Operating expense
Research & development 1.3B 1.5B 1.4B 1.6B
Selling general and admin 1.4B 1.4B 1.3B 1.9B
Other operating expenses
Operating income 3.5B 2.7B 2.5B 2.4B
Non operating interest income
Income 88M 73M 94M 85M
Expense 256M 254M 260M 249M
Other income expense 312M -115M -675M -110M
Pretax income 3.6B 2.4B 1.6B 2.2B
Tax provision 589M 468M 334M 385M
Net income 3.1B 2.0B 1.3B 1.8B
Basic EPS 1.6 1.1 1.4
Diluted EPS 1.6 1.0 1.4
Basic average shares 1.2B 1.2B 1.2B
Diluted average shares 1.3B 1.3B 1.3B
EBITDA 4.3B 3.5B 3.3B 3.2B
Net income from continuing op. 3.1B 2.0B 1.3B 1.8B
Minority interests 0 0 0 0
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 7 hours 18 minutes

02:11
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).